Is Stage 1 Hypertension as Defined in ACC/AHA Guidelines Associated with Any Events?

New information has been published fast, and what we thought we knew about hypertension has also changed fast. One of the biggest differences between American and European hypertension guidelines is whether patients with systolic blood pressure (BP) 130/139 mmHg and diastolic BP 80/89 mmHg are considered hypertensive or not. The only place where enough patients with these levels could be found is China and, while a Chinese population is clearly different from a Latin America population, this work answered some of our questions.

¿Es seguro dar el alta el mismo día luego de una angioplastia?The effect of considering these patients as hypertensive as per American guidelines is observed in a reduction of cardiovascular risk among young or middle-aged patients, but no benefit is observed in patients ≥60 years old.

 

This work included 21,441 patients over 35 years old without cardiovascular disease at baseline for this registry. The follow-up was 20 years for the entire cohort and the risk of cardiovascular disease calculated could be attributed to the new stage 1 hypertension classification.


Read also: New European Hypertension Guidelines Contrast with American Recommendations.


The risk of cardiovascular disease for patients from 35 to 59 years old with stage 1 hypertension almost doubled the risk for people with BP <120/80 (hazard ratio [HR] for cardiovascular disease: 1.78; 95% confidence interval [CI]: 1.50 to 2.11). The increase in the specific risk of coronary disease was similar (HR: 1.77; 95% CI: 1.33 to 2.36), while the increase in the risk of stroke was somewhat higher (HR: 1.79; 95% CI: 1.45 to 2.22). The increase in the rate of cardiovascular death was more than double (HR: 2.50; 95% CI: 1.66 to 3.77), which is worrisome.

 

The proportions of cardiovascular death and events attributable to stage 1 hypertension among participants aged 35 to 59 years were 26.5% and 13.4%, respectively.

 

However, among participants aged ≥60 years, no higher risk was observed in patients with stage 1 hypertension compared with those with BP <120/80 mmHg.


Read also: New High Blood Pressure Guidelines.


Over 15 years, 65% of young patients with stage 1 hypertension evolved to 140/90 mmHg or higher, and their risk rates tripled compared with the remaining 35% who maintained a BP lower than 130/80 mmHg.

 

Conclusion

The effect of considering patients with BP between 130/139 and 80/89 mmHg (American College of Cardiology/American Heart Association [ACC/AHA] stage 1 hypertension) as hypertensive is observed only in young and middle-aged patients, while those aged ≥60 years did not evidence any association between these figures and cardiovascular risk.

 

Original title: Long-Term Cardiovascular Risk Associated with Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline.

Reference: Yue Qi et al. J Am Coll Cardiol 2018;72:1201-10.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | P2Y12 Inhibitor Monotherapy After Complex PCI in ACS: Results From the NEO-MINDSET COMPLEX Subanalysis

This is a summary of the NEO-MINDSET COMPLEX subanalysis, presented by Dr. Guy Prado at EuroPCR 2026, which evaluated P2Y12 inhibitor monotherapy versus dual...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...